D. Surmeier
Neurology · 2000–2020
A researcher in the Science corpus: 11 papers; trusts 11 researchers and is trusted by 24 researchers here, as inferred from the citation graph.
Subfields
- Neurology — 125 citations into it; #106 of 1,455 by trust here, #157 by citations
- Cellular and Molecular Neuroscience — 108 citations into it; #326 of 2,998 by trust here, #292 by citations
- Cognitive Neuroscience — 34 citations into it
- Developmental Neuroscience — 11 citations into it
- Genetics — 8 citations into it
- Pharmacology — 6 citations into it
- Electrical and Electronic Engineering — 5 citations into it
Whom D. Surmeier trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
- J. Sweatt
- A. Kreitzer
- Panayiota Poirazi
- Bernard W. Balleine
- Wolfram Schultz
- R. Malenka
- H. Braak
- Clifford B. Saper
- M. Goedert
- Bartlett W. Mel
Who trusts D. Surmeier overall
- S. Sesack
- Charles R. Gerfen
- T. Jay
- Anthony A. Grace
- Michael J Frank
- V. Pawlak
- Julien Vitay
- R. Malenka
- A. Kreitzer
- N. Tritsch
Papers from D. Surmeier's perspective
Ordered by how strongly the researchers D. Surmeier trusts endorse each paper. Same corpus, a different order for every researcher.
- A gene expression atlas of the central nervous system based on bacterial artificial chromosomes (Nature)
- Move to the rhythm: oscillations in the subthalamic nucleus-external globus pallidus network. (Trends in Neurosciences)
- Genome-wide atlas of gene expression in the adult mouse brain (Nature)
- Gene Expression Omnibus: NCBI gene expression and hybridization array data repository (Nucleic Acids Res.)
- A database for post-genome analysis.
- Impact of active dendrites and structural plasticity on the memory capacity of neural tissue.
- Dopamine-mediated regulation of corticostriatal synaptic plasticity. (Trends in Neurosciences)
- Pimavanserin for patients with Parkinson's disease psychosis: a randomised, placebo-controlled phase 3 trial. (The Lancet)
- Multi-organ distribution of phosphorylated α-synuclein histopathology in subjects with Lewy body disorders (Acta Neuropathologica)
- A mutation in VPS35, encoding a subunit of the retromer complex, causes late-onset Parkinson disease. (American Journal of Human Genetics)
Their papers
- D1 and D2 dopamine-receptor modulation of striatal glutamatergic signaling in striatal medium spiny neurons. (2007) — 1,132 citations
- Development of a BACarray translational profiling approach for the molecular characterization of CNS cell types (2008) — 1,118 citations
- Floor plate-derived dopamine neurons from hESCs efficiently engraft in animal models of PD (2011) — 1,716 citations
- Negative feedback control of neuronal activity by microglia (2020) — 814 citations
- Dopamine oxidation mediates mitochondrial and lysosomal dysfunction in Parkinson’s disease (2017) — 766 citations
- Selective neuronal vulnerability in Parkinson disease (2017) — 958 citations
- Past, Present, and Future of Parkinson’s Disease: A Special Essay on the 200th Anniversary of the Shaking Palsy (2017) — 734 citations
- Modulation of striatal projection systems by dopamine (2011) — 1,594 citations
- Dichotomous Dopaminergic Control of Striatal Synaptic Plasticity (2008) — 1,202 citations
- ‘Rejuvenation’ protects neurons in mouse models of Parkinson’s disease (2007) — 903 citations
- Dopaminergic modulation of neuronal excitability in the striatum and nucleus accumbens. (2000) — 996 citations